Novartis recently filed a lawsuit against the Food and Drug Administration in a federal court in Washington, D.C., claiming that the FDA's approval of a generic version of Entresto is unlawful, per a ...
On September 27, 2022, Judge Richard Andrews of the District of Delaware granted Novartis’s motion to dismiss declaratory judgment (“DJ”) counterclaims raised by two generic drug manufacturers in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results